More than 10 years ago, Medline’s Corporate Social Responsibility (CSR) efforts started in the areas we thought we could make the largest immediate impact. These initial efforts eventually expanded into three key initiative pillars, which would drive our efforts in the years to follow: Global Health, Community Impact and Sustainability.

In 2021, Medline focused on investments in renewable energy, elevating clinical knowledge in low-resource countries and continuing to address social determinants of health. This 2021 CSR Report details the work completed last year to make a positive and substantive impact in these areas of focus. It also illustrates our commitment to building new, strong foundations and measurable results across the communities in which we live and work.

Beyond this year’s highlights, this report also represents another step forward in our work to become better corporate citizens. In 2022 and beyond, Medline will adapt a new approach to responsible business, focusing our efforts on key Environmental, Social and Governance (ESG) issues.

Our adoption of ESG is a natural evolution of our CSR efforts, comprising of priorities and values across all regions, and expanding upon current activities to include additional areas of impact: emissions reduction targets, a deeper commitment to diversity and inclusion throughout our ranks, an ethical sourcing program spanning our supply chain, good governance and more.

We find this report and shift toward ESG especially meaningful—each represents the culmination of success and impact of CSR at Medline to date, and holds our efforts to make a positive impact, both past and present, to a higher standard.

Despite the global challenges we have all faced over the past few years, so many employees continue to donate their time and resources to make a positive impact in the world. We couldn’t be prouder of the individual and collective efforts of all those who contributed.